Limula

About:

Limula offers a modular and automated solution for on-demand and at-scale manufacturing of cell therapies.

Website: https://www.limula.ch

Top Investors: Verve Ventures, Venture Kick, European Innovation Council, Innosuisse, LifeX Ventures

Description:

Limula provides a unique platform technology enabling scale out of cell therapy production. Our patent-granted solution is combining a bioreactor and a centrifuge into one device, for the first time. Our product is composed of hardware, software and consumables, allowing healthcare providers to safely manufacture CGT in a decentralised manner. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments.

Total Funding Amount:

$15.2M

Headquarters Location:

La Tour-de-peilz, Vaud, Switzerland

Founded Date:

2020-11-06

Contact Email:

info(AT)limula.ch

Founders:

Luc Henry, Thomas Eaton, Yann Pierson

Number of Employees:

1-10

Last Funding Date:

2024-05-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai